Effects of opioid antagonists on anticonvulsants and hypnotic activity of benzodiazepines

Polish Journal of Pharmacology

Volumn 48, Issue 4, 1996, Pages 409-414

  Fidecka, Sylwia ^a   Langwiński, Romuald ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

benzodiazepines; hypnosis; mice; naloxone; naltrexone; seizures

Indexed keywords

BENZODIAZEPINE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; ENDORPHIN; ESTAZOLAM; HEXOBARBITAL; NALOXONE; NALTREXONE; OPIATE ANTAGONIST; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PROTECTION; SLEEP TIME; SUBCUTANEOUS DRUG ADMINISTRATION; TONIC SEIZURE;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; DRUG INTERACTIONS; ELECTROSHOCK; ESTAZOLAM; GABA MODULATORS; HYPNOTICS AND SEDATIVES; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PENTYLENETETRAZOLE; SEIZURES;

EID: 0029859528     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ågmo A., Galvan A., Heredia A., Morales M.: Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review. Psychopharmacology, 1995, 120, 186-194.
2. Ashton H.: Guidelines for the rational use of benzodiazepines. When and who to use. Drugs, 1994, 48, 25-40.
3. Brady L. S., Mansbach R. S., Skurdal D. N., Muldoon S. M., Barrett J. E.: Reversal of the antinociceptive effects of centrally-administered morphine by the benzodiazepine receptor antagonist Ro 15-1788. Life Sci., 1984, 35, 2593-2600.
4. Castellano C., Filibeck V., Pavone F.: Naltrexone-reversible effects of flunitrazepam on locomotor activity and passive avoidance behaviour in mice. Eur. J. Pharmacol. 1984, 104, 111-116.
5. Cooper S. J.: Benzodiazepine-opiate antagonist interactions in relation to anxiety and appetite. Trends Pharmacol. Sci., 1983, 4, 456-458.
6. Dingledine R., Iversen L. L., Breuker E.: Naloxone as a GABA antagonist: Evidence from iontophoretic, receptor binding and convulsant studies. Eur. J. Pharmacol., 1978, 47, 19-27.
7. Duka Th., Cumin R., Haefely W., Herz A.: Naloxone blocks the effects of diazepam and meprobamate on conflict behaviour in rats. Pharmacol. Biochem. Behav., 1981, 15, 115-117.
8. Duka T., Wüster M., Herz A.: Benzodiazepines modulate striatal enkephalin levels via a GABA-ergic mechanism. Life Sci, 1980, 26, 771-776.
9. Gemperle M., Kapp W.: Midazolam and anaesthesia. Brit. J. Clin. Pharmacol., 1983, 16, 1878-1908.
10. 3H]-flunitrazepam binding. Neuro-Report, 1993, 4, 987-990.
11. Haefely W.: Benzodiazepines. Mechanisms of actions. In: Antiepileptic Drugs. Eds. Levy R., Mattson R., Meldrum B., Penry J. K., Dreifuss F. E., Raven Press, New York, 1989, 721-734.
12. Haefely W., Pole P.: Electrophysiological studies on the interactions of anxiolytic drugs witch GAB Aergic mechanisms. In: Anxiolytics: Neurochemical, Behavioral and Clinical Perspectives. Eds. Malick J. B., Enna S. J., Yamamura J. H., Raven Press, New York, 1983, 113-145.
13. Lopez F., Miller L. G., Thompson M. L., Schatzki A., Chesley S., Greenblatt D. J., Shader R. L: Chronic morphine administration augments benzodiazepine binding and GABAA receptor function. Psychopharmacology, 1990, 101, 545-549.
14. Martin W. R.: Pharmacology of opioids. Pharmacol. Rev., 1984, 35, 283-323.
15. Mendelson W. B., Monti D.: Do benzodiazepine induce sleep by a GABAegric mechanisms? Life Sci., 1993, 53, PL 81-87.
16. Naughton N., Huffman W. E., Larscheid P., Cook J. M., Albrecht R. F., Miletich D. J.: A benzodiazapine antagonist inhibits the cerebral metabolic and respiratory depressant effects of fentanyl. Life Sci., 1985, 36, 2239-2245.
17. Nicolai P. M., DiCarlo F., Alfani R., Cerbo M., Smeriglio S., Borgo E., Cipriani S., Targuini S., Malizia E.: La nostra esperienza sull'intossicazione acuta da flunitrazepam. Riv. Tossicol. Sperim. Clin., 1981, 3, 47.
18. Nowakowska E., Chodera A.: Studies on the involvement of opioid mechanism in the locomotor effects of benzodiazepines in rats. Pharmacol. Biochem. Behav., 1991, 38, 265-266.
19. Paakkari P., Feuerstein G.: Antagonism of dermorphin-induced catalepsy with naloxone, TRH-analog CG3703 and the benzodiazepine antagonist, Ro 15-1788. Neuropharmacology, 1988, 27, 1007-1012.
20. Sagratella S., Massotti M.: Convulsant and anticonvulsant effects of opioids: Relationship to GABA-mediated transmission. Neuropharmacology, 1982, 21, 991-1000.
21. Sansone J., Vetulani J.: Effect of naloxone on the locomotor stimulatory action of chlordiazepoxide in mice. Pharmacol. Biochem. Behav., 1988, 31, 371-373.
22. Sawynok J., Pinsky C., LaBella F. S.: On the specificity of naloxone as an opiate antagonist. Life Sci., 1979, 25, 1621-1632.
23. Schweitzer P. K., Koshorek G., Muehlbach M. J., Morris D. D., Roehrs T., Walsh J. K., Roth T.: Effects of estazolam and triazolam on transient insomnia associated with phase-shifted sleep. Hum. Psychopharmacol. Clin. Exp., 1991, 6, 99-107.
24. Stapleton J. M., Lind M. D., Merriman V. J., Reid L. D.: Naloxone inhibits diazepam-induced feeding in rats. Life Sci., 1979, 24, 2421-2426.
25. Swinyard E. A., Brown W. C., Goodman L. S.: Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther, 1952, 106, 319-330.
26. Swinyard E. A., Castellion A. W.: Anticonvulsant properties of some benzodiazepines. J. Pharmacol. Exp. Ther., 1966, 151, 369-375.
27. Swinyard E. A., White H. S., Wolf H. H.: Mechanisms of anticonvulsant drugs. ISI Atlas Sci. Pharmacol., 1988, 2, 95-98.
28. Wong P. T.-H., Yoong Y. L., Gwee M. C. E.: Acute tolerance to diazepam induced by benzodiazepines. Clin. Exp. Pharmacol. Physiol, 1986, 13, 1-8.
29. Woods J. H., Katz J. L., Winger G.: Abuse liability of benzodiazepines. Pharmacol. Rev., 1987, 39, 251-419.